期刊文献+

PEG2000-DSPE含量不同的酒石酸长春瑞滨脂质体的制备和评价 被引量:4

Preparation and Evaluation of Vinorelbine Tartrate Liposomes with Different PEG2000-DSPE Contents
原文传递
导出
摘要 采用蔗糖八硫酸酯三乙胺梯度法制备聚乙二醇2000-二硬脂酰磷脂酰乙醇胺(PEG2000-DSPE)摩尔比分别为6%、3%和1%的酒石酸长春瑞滨(1)脂质体。考察了3种处方脂质体的药物粒径、ζ电位、包封率、体外释放度和稳定性。以1注射液为对照,比较3种脂质体对裸鼠SW620移植瘤的生长抑制作用。结果表明,3种处方脂质体的体外特性基本一致,且4℃条件下放置6个月,各样品的主要质量指标均未发生显著变化。药效学研究结果表明,PEG2000-DSPE含量由高至低的各脂质体组抑瘤率分别为52.8%、72.1%和61.8%,而1注射液组抑瘤率仅47%。 The vinorelbine tartrate (1) liposomes with 6%,3% and 1% molar ratios of polyethylene glycol 2000-distearoyl phosphatidyl ethanolamine (PEG2000-DSPE) were prepared by sucrose octasulfate gradient method.The particle size,ξ potential,entrapment efficiency,in vitro release and stability of the three types of liposomes were detected.The growth inhibition effects of three types of liposomes on SW620 cells transplanted into nude mice were investigated with 1 injection as the contrast.The results showed that the in vitro characteristics of the three types of liposomes were similar.Moreover,the main quality indicators of the three types of liposomes stored at 4 ℃ for 6 months had no significant changes.The tumor growth inhibition effects of the liposomes with 6 %,3 % and 1% of PEG2000-DSPE were 52.8 %,72.1% and 61.8 %,respectively.Meanwhile,the tumor inhibition of 1 injection was only 47 %.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2014年第11期1046-1049,共4页 Chinese Journal of Pharmaceuticals
基金 国家"重大新药创制"科技重大专项(2010ZX09401-302-4-2)
关键词 酒石酸长春瑞滨 脂质体 PEG2000-DSPE 蔗糖八硫酸酯 肿瘤抑制 vinorelbine tartrate liposome PEG2000-DSPE sucrose octasulfate tumor inhibition
  • 相关文献

参考文献5

  • 1Jones SF, Bun'is HA 3rd. Vinorelbine: a new antineoplastic drug for the treatment of non-small-cell lung cancer [J]. Ann Pharmacother, 1996, 30 (5) : 501-506.
  • 2Crawford J. Update: vinorelbine (navelbine) in non-small cell lung cancer [J]. Semin Oncol, 1996, 23 (2 Suppl 5) : 2-7.
  • 3Johnson SA, Harper P, Hortobagyi GN, et al. Vinorelbine: an overview [J]. Cancer TreatRev, 1996, 22 (2) : 127-142.
  • 4Li CL, Cui JX, Wang CX, et al. Development of pegylated liposomal vinorelbine formulation using "post-insertion" technology [J]. IntJPharm, 2010, 391 (1-2): 230-236.
  • 5Drummond DC, Noble CO, Guo Z, et al. Improved pharma- cokinetics and efficacy of a highly stable nanoliposomal vinorelbine [ J]. J Pharmacol Exp Ther, 2009, 328 (1) : 321-330.

同被引文献30

  • 1盛滢,孙芙蓉,于爽.静脉注射重酒石酸长春瑞滨治疗非小细胞肺癌的护理观察[J].山西医药杂志,2005,34(5):435-435. 被引量:3
  • 2王玮,尹宗宁,李铜铃,李毓琦,邹敬伟.蚓激酶白蛋白纳米粒中的酶活力测定[J].中国新药杂志,2005,14(8):1019-1021. 被引量:2
  • 3孙维彤,黄桂华,叶杰胜,张娜.鱼精蛋白凝聚法测定脂质体和纳米脂质体包封率[J].中国药学杂志,2006,41(22):1716-1720. 被引量:34
  • 4Hui Zhang,Zhi-yuan Wang,Wei Gong,Zhi-ping Li,Xing-guo Mei,Wan-liang Lv.Development and characteristics of temperature-sensitive liposomes for vinorelbine bitartrate[J]. International Journal of Pharmaceutics . 2011 (1)
  • 5Shih-Hung Yang,Chia-Chi Lin,Zhong-Zhe Lin,Yun-Long Tseng,Ruey-Long Hong.A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor[J]. Investigational New Drugs . 2012 (1)
  • 6Chun Lei Li,Jing Xia Cui,Cai Xia Wang,Lan Zhang,Yan Hui Li,Li Zhang,Xian Xiu,Yong Feng Li,Na Wei.Development of pegylated liposomal vinorelbine formulation using “post-insertion” technology[J]. International Journal of Pharmaceutics . 2010 (1)
  • 7Galano G, Caputo M, Tecce MF, et al. Efficacy and tolerability of vinorelbine in the cancer therapy[J]. Curr Drug Saf, 2011, 6(3): 185-193.
  • 8Bahadori F, Topcu G, Eroqiu MS, et al. A new lipid-based nano formulation of vinorelbine[J]. AAPS Pharm Sci Tech, 2014, 15(5): 1138-1148.
  • 9Wakelee HA, Middleton G, Dunlop D, et al. A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)[J]. Cancer Chemother Pharmacol, 2012, 69(3): 815-824.
  • 10Shi JF, Sun MG, Li XY, et al. A combination of targeted sunitinib liposomes and targeted vinorelbine liposomes for treating invasive breast cancer[J]. J Biomed Nanatechnol, 2015, 11(9): 1568-1582.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部